You just read:

Akcea and Ionis Announce Positive Results from Pivotal Study of Volanesorsen in Patients with Familial Chylomicronemia Syndrome (FCS)

News provided by

Ionis Pharmaceuticals, Inc.

06 Mar, 2017, 07:30 ET